Dataset Information
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease.
Ontology highlight
ABSTRACT: Introduction
Mononuclear phagocytes play a critical role during Alzheimer's disease (AD) pathogenesis due to their contribution to innate immune responses and amyloid beta (A?) clearance mechanisms.Methods
Blood-derived monocytes (BDMs) and monocyte-derived macrophages (MDMs) were isolated from blood of AD, mild cognitive impairment (MCI) patients, and age-matched healthy controls for molecular and phenotypic comparisons.Results
The chemokine/chemokine receptor CCL2/CCR2 axis was impaired in BDMs from AD and MCI patients, causing a deficit in cell migration. Changes were also observed in MDM-mediated phagocytosis of A? fibrils, correlating with alterations in the expression and processing of the triggering receptor expressed on myeloid cells 2 (TREM2). Finally, immune-related microRNAs (miRNAs), including miR-155, -154, -200b, -27b, and -128, were found to be differentially expressed in these cells.Discussion
This work provides evidence that chemotaxis and phagocytosis, two crucial innate immune functions, are impaired in AD and MCI patients. Correlations with miRNA levels suggest an epigenetic contribution to systemic immune dysfunction in AD.
SUBMITTER: Guedes JR
PROVIDER: S-EPMC4879648 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Publications
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease.
Alzheimer's & dementia (Amsterdam, Netherlands) 20151212
<h4>Introduction</h4>Mononuclear phagocytes play a critical role during Alzheimer's disease (AD) pathogenesis due to their contribution to innate immune responses and amyloid beta (Aβ) clearance mechanisms.<h4>Methods</h4>Blood-derived monocytes (BDMs) and monocyte-derived macrophages (MDMs) were isolated from blood of AD, mild cognitive impairment (MCI) patients, and age-matched healthy controls for molecular and phenotypic comparisons.<h4>Results</h4>The chemokine/chemokine receptor CCL2/CCR2 ...[more]
